Gotham Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.38M | Buy |
109,725
+62,416
| +132% | +$1.35M | 0.01% | 870 |
|
|
2025
Q1 | $1.15M | Buy |
47,309
+8,356
| +21% | +$203K | 0.01% | 963 |
|
|
2024
Q4 | $813K | Buy |
38,953
+2,812
| +8% | +$58.7K | 0.01% | 971 |
|
|
2024
Q3 | $718K | Buy |
36,141
+2,444
| +7% | +$48.6K | 0.01% | 997 |
|
|
2024
Q2 | $522K | Sell |
33,697
-1,491
| -4% | -$23.1K | 0.01% | 1075 |
|
|
2024
Q1 | $561K | Sell |
35,188
-2,314
| -6% | -$36.9K | 0.01% | 1004 |
|
|
2023
Q4 | $630K | Sell |
37,502
-76,504
| -67% | -$1.29M | 0.01% | 920 |
|
|
2023
Q3 | $1.33M | Buy |
114,006
+3,532
| +3% | +$41.3K | 0.03% | 681 |
|
|
2023
Q2 | $1.48M | Sell |
110,474
-28,977
| -21% | -$389K | 0.03% | 641 |
|
|
2023
Q1 | $2.31M | Buy |
139,451
+120,406
| +632% | +$2M | 0.06% | 468 |
|
|
2022
Q4 | $354K | Sell |
19,045
-31,130
| -62% | -$579K | 0.01% | 999 |
|
|
2022
Q3 | $644K | Buy |
+50,175
| New | +$644K | 0.02% | 789 |
|
|
2020
Q4 | – | Sell |
-32,653
| Closed | -$97K | – | 1015 |
|
|
2020
Q3 | $97K | Sell |
32,653
-37,219
| -53% | -$111K | ﹤0.01% | 983 |
|
|
2020
Q2 | $323K | Sell |
69,872
-57,062
| -45% | -$264K | 0.01% | 847 |
|
|
2020
Q1 | $489K | Buy |
126,934
+90,420
| +248% | +$348K | 0.01% | 725 |
|
|
2019
Q4 | $137K | Sell |
36,514
-3,306
| -8% | -$12.4K | ﹤0.01% | 1065 |
|
|
2019
Q3 | $211K | Buy |
+39,820
| New | +$211K | ﹤0.01% | 1001 |
|